Longitudinal monitoring of T cell dynamics in metastatic breast cancer via a remote diagnostic implant

Abstract Metastatic triple negative breast cancer poses a significant health challenge due to rapid progression and limited treatment options. Immunotherapies targeting T cell responses against metastatic tumors depend on the presence of specific T cell phenotypes, which dynamically evolve with dise...

Full description

Saved in:
Bibliographic Details
Main Authors: Ian A. Schrack, Rebecca S. Pereles, Brian C. Ross, Jeffrey A. Ma, Russell R. Urie, Emily R. Irish, Guillermo Escalona, Kate V. Griffin, Kathryn Kang, Jacqueline S. Jeruss, Lonnie D. Shea Ph.D.
Format: Article
Language:English
Published: Wiley 2024-12-01
Series:ImmunoMedicine
Subjects:
Online Access:https://doi.org/10.1002/imed.70000
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849320693938782208
author Ian A. Schrack
Rebecca S. Pereles
Brian C. Ross
Jeffrey A. Ma
Russell R. Urie
Emily R. Irish
Guillermo Escalona
Kate V. Griffin
Kathryn Kang
Jacqueline S. Jeruss
Lonnie D. Shea Ph.D.
author_facet Ian A. Schrack
Rebecca S. Pereles
Brian C. Ross
Jeffrey A. Ma
Russell R. Urie
Emily R. Irish
Guillermo Escalona
Kate V. Griffin
Kathryn Kang
Jacqueline S. Jeruss
Lonnie D. Shea Ph.D.
author_sort Ian A. Schrack
collection DOAJ
description Abstract Metastatic triple negative breast cancer poses a significant health challenge due to rapid progression and limited treatment options. Immunotherapies targeting T cell responses against metastatic tumors depend on the presence of specific T cell phenotypes, which dynamically evolve with disease progression and treatment. Herein, we investigate T cell phenotype dynamics throughout metastatic disease progression, focusing on both the metastatic site in the lung and a biomaterial implant that serves as a synthetic metastatic niche, with the latter providing an accessible, non‐vital tissue for longitudinal analysis. Regulatory T cells were reduced at the lung and scaffold implant sites of metastasis following disease onset and progression relative to healthy mice, while Th1 and Th17 populations remained relatively stable. CD8+ T cells transitioned from naïve and central memory to effector memory with disease progression. Additionally, functional analyses involving the metastatic tissues suggested the primary T cell suppressive mechanism was reduced migration, with no impact on T cell activation. Blood‐based analyses demonstrated some of these phenotypic dynamics yet do not recapitulate the functional assays. Collectively, the scaffold provides a platform for dynamically monitoring T cell phenotypes and functions similar to the metastatic lung, enabling longitudinal monitoring of disease progression that could stratify patient populations.
format Article
id doaj-art-ee5d96460cdc44d1bd2c7e3eed8f3715
institution Kabale University
issn 2510-5345
language English
publishDate 2024-12-01
publisher Wiley
record_format Article
series ImmunoMedicine
spelling doaj-art-ee5d96460cdc44d1bd2c7e3eed8f37152025-08-20T03:50:00ZengWileyImmunoMedicine2510-53452024-12-0142n/an/a10.1002/imed.70000Longitudinal monitoring of T cell dynamics in metastatic breast cancer via a remote diagnostic implantIan A. Schrack0Rebecca S. Pereles1Brian C. Ross2Jeffrey A. Ma3Russell R. Urie4Emily R. Irish5Guillermo Escalona6Kate V. Griffin7Kathryn Kang8Jacqueline S. Jeruss9Lonnie D. Shea Ph.D.10Department of Biomedical Engineering University of Michigan Ann Arbor Michigan USADepartment of Biomedical Engineering University of Michigan Ann Arbor Michigan USADepartment of Biomedical Engineering University of Michigan Ann Arbor Michigan USADepartment of Biomedical Engineering University of Michigan Ann Arbor Michigan USADepartment of Biomedical Engineering University of Michigan Ann Arbor Michigan USADepartment of Biomedical Engineering University of Michigan Ann Arbor Michigan USADepartment of Biomedical Engineering University of Michigan Ann Arbor Michigan USADepartment of Biomedical Engineering University of Michigan Ann Arbor Michigan USADepartment of Biomedical Engineering University of Michigan Ann Arbor Michigan USADepartment of Biomedical Engineering University of Michigan Ann Arbor Michigan USADepartment of Biomedical Engineering University of Michigan Ann Arbor Michigan USAAbstract Metastatic triple negative breast cancer poses a significant health challenge due to rapid progression and limited treatment options. Immunotherapies targeting T cell responses against metastatic tumors depend on the presence of specific T cell phenotypes, which dynamically evolve with disease progression and treatment. Herein, we investigate T cell phenotype dynamics throughout metastatic disease progression, focusing on both the metastatic site in the lung and a biomaterial implant that serves as a synthetic metastatic niche, with the latter providing an accessible, non‐vital tissue for longitudinal analysis. Regulatory T cells were reduced at the lung and scaffold implant sites of metastasis following disease onset and progression relative to healthy mice, while Th1 and Th17 populations remained relatively stable. CD8+ T cells transitioned from naïve and central memory to effector memory with disease progression. Additionally, functional analyses involving the metastatic tissues suggested the primary T cell suppressive mechanism was reduced migration, with no impact on T cell activation. Blood‐based analyses demonstrated some of these phenotypic dynamics yet do not recapitulate the functional assays. Collectively, the scaffold provides a platform for dynamically monitoring T cell phenotypes and functions similar to the metastatic lung, enabling longitudinal monitoring of disease progression that could stratify patient populations.https://doi.org/10.1002/imed.70000biomarkersbiomaterialsimmune monitoringmetastasis
spellingShingle Ian A. Schrack
Rebecca S. Pereles
Brian C. Ross
Jeffrey A. Ma
Russell R. Urie
Emily R. Irish
Guillermo Escalona
Kate V. Griffin
Kathryn Kang
Jacqueline S. Jeruss
Lonnie D. Shea Ph.D.
Longitudinal monitoring of T cell dynamics in metastatic breast cancer via a remote diagnostic implant
ImmunoMedicine
biomarkers
biomaterials
immune monitoring
metastasis
title Longitudinal monitoring of T cell dynamics in metastatic breast cancer via a remote diagnostic implant
title_full Longitudinal monitoring of T cell dynamics in metastatic breast cancer via a remote diagnostic implant
title_fullStr Longitudinal monitoring of T cell dynamics in metastatic breast cancer via a remote diagnostic implant
title_full_unstemmed Longitudinal monitoring of T cell dynamics in metastatic breast cancer via a remote diagnostic implant
title_short Longitudinal monitoring of T cell dynamics in metastatic breast cancer via a remote diagnostic implant
title_sort longitudinal monitoring of t cell dynamics in metastatic breast cancer via a remote diagnostic implant
topic biomarkers
biomaterials
immune monitoring
metastasis
url https://doi.org/10.1002/imed.70000
work_keys_str_mv AT ianaschrack longitudinalmonitoringoftcelldynamicsinmetastaticbreastcancerviaaremotediagnosticimplant
AT rebeccaspereles longitudinalmonitoringoftcelldynamicsinmetastaticbreastcancerviaaremotediagnosticimplant
AT briancross longitudinalmonitoringoftcelldynamicsinmetastaticbreastcancerviaaremotediagnosticimplant
AT jeffreyama longitudinalmonitoringoftcelldynamicsinmetastaticbreastcancerviaaremotediagnosticimplant
AT russellrurie longitudinalmonitoringoftcelldynamicsinmetastaticbreastcancerviaaremotediagnosticimplant
AT emilyrirish longitudinalmonitoringoftcelldynamicsinmetastaticbreastcancerviaaremotediagnosticimplant
AT guillermoescalona longitudinalmonitoringoftcelldynamicsinmetastaticbreastcancerviaaremotediagnosticimplant
AT katevgriffin longitudinalmonitoringoftcelldynamicsinmetastaticbreastcancerviaaremotediagnosticimplant
AT kathrynkang longitudinalmonitoringoftcelldynamicsinmetastaticbreastcancerviaaremotediagnosticimplant
AT jacquelinesjeruss longitudinalmonitoringoftcelldynamicsinmetastaticbreastcancerviaaremotediagnosticimplant
AT lonniedsheaphd longitudinalmonitoringoftcelldynamicsinmetastaticbreastcancerviaaremotediagnosticimplant